PATH insider filing: 240,874 shares via Morgan Stanley, $3.75M

Rhea-AI Filing Summary

UiPath, Inc. reported a proposed insider sale under Rule 144 for 240,874 common shares with an aggregate market value of $3,752,816.92. The filing shows the shares are to be sold on or about 10/09/2025 on the NYSE through Morgan Stanley Smith Barney LLC. The position being sold was acquired in two tranches: 148,009 shares from an exercise of stock options on 10/09/2025 (paid in cash) and 92,865 shares from restricted stock units on 01/01/2024.

The filer certifies there were no sales by the same person in the past three months and affirms no undisclosed material adverse information is known. The form is marked as a LIVE filing and includes broker and share-outstanding details: 453,568,899 shares outstanding were reported in the table.

Positive

• Transparent disclosure of planned insider sale with broker and exact share counts
• No sales in the past three months reported for the selling person
• Breakout of acquisition types shows shares came from option exercise and RSUs

Negative

• Insider intends to sell 240,874 shares valued at $3,752,816.92, which may be viewed negatively by some investors
• Large outstanding share base of 453,568,899 shares means the sale is a small percentage but still increases float

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	240874	3752816.92	453568899	10/09/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/09/2025	Exercise of Stock Options	Issuer			148009	10/09/2025	Cash
Common	01/01/2024	Restricted Stock Units	Issuer			92865	01/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did UiPath (PATH) disclose in this Form 144?

The filing shows a proposed sale of 240,874 common shares valued at $3,752,816.92, to be executed around 10/09/2025 on the NYSE through Morgan Stanley Smith Barney LLC.

How were the 240,874 shares acquired?

The shares consist of 148,009 from an exercise of stock options on 10/09/2025 (paid in cash) and 92,865 from restricted stock units granted on 01/01/2024.

Did the filer report any sales of UiPath shares in the past three months?

No. The section for securities sold during the past three months states "Nothing to Report".

Who is the broker handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

How many shares outstanding did the filing state for UiPath?

The filing lists 453,568,899 shares outstanding in the securities table.